Skull Base 2003; 13(4): 229-234
DOI: 10.1055/s-2004-817699
CASE REPORT

Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Does Catecholamine Secretion from Head and Neck Paragangliomas Respond to Radiotherapy? Case Report and Literature Review

Francis T. Hall1 , Bayardo  Perez-Ordonez2 , Robert G. MacKenzie3 , Ralph W. Gilbert1
  • 1Otolaryngology Head and Neck Surgery, Princess Margaret Hospital, Toronto, Ontario, Canada
  • 2Pathology, Princess Margaret Hospital, Toronto, Ontario, Canada
  • 3Department of Radiation Oncology, Sunnybrook and Women's Health Science Centre, Toronto, Ontario, Canada
Further Information

Publication History

Publication Date:
03 February 2004 (online)

ABSTRACT

We report a 38-year-old woman with a malignant catecholamine-secreting vagal paraganglioma. In the preceding year she had intermittent severe frontoparietal headaches. While she was receiving radiotherapy (35 Gy in 15 fractions) she developed palpitations, which steadily worsened over the following three years. A repeat CT scan showed no change in the size of the tumor. Urinary catecholamines were elevated and a MIBG scan showed increased uptake in the region of the vagal paraganglioma. She underwent near total resection of her tumor via a Fisch type C approach. Pathological examination showed a paraganglioma with metastasis involving a cervical lymph node. The palpitations and headaches resolved completely after surgery. This report and other published case reports suggest that catecholamine secretion from head and neck paragangliomas does not appear to respond to radiotherapy. Patients with cardiovascular symptoms from catecholamine-secreting paragangliomas are best managed surgically.

REFERENCES

  • 1 Netterville J L, Jackson C G, Miller F R, Wanamaker J R, Glasscock M E. Vagal paraganglioma. A review of 46 patients treated during a 20 year period.  Arch Otolaryngol Head Neck Surg . 1998;  124 1133-1140
  • 2 Druck N S, Spector G J, Ciralsky R H, Ogura J H. Malignant glomus vagale.  Arch Otolaryngol . 1976;  102 534-536
  • 3 Henrich M C, Harris A E, Bell W R. Metastatic intravagal paraganglioma.  Am J Med . 1985;  78 1017-1024
  • 4 Schwaber M K, Glasscock M E, Jackson C G, Nissen A J, Smith P G. Diagnosis and management of catecholamine secreting glomus tumors.  Laryngoscope . 1984;  94 1008-1015
  • 5 Cummings B J, Beale F A, Garrett P G. The treatment of glomus tumors in the temporal bone by megavoltage radiation.  Cancer . 1984;  53 2635-2640
  • 6 Powell S, Peters N, Harmer C. Chemodectoma of the head and neck: results of treatment in 84 patients.  Int J Radiat Oncol Biol Physiol . 1992;  22 919-924
  • 7 Elshaikh M A, Mahmoud-Ahmed A S, Kinney S E. Recurrent head and neck chemodectomas: a comparison of surgical and radiotherapeutic results.  Int J Radiat Oncol Physio . 2002;  52 953-956
  • 8 Hinerman R W, Mendenhall W M, Amdur R J, Stringer S P, Antonelli P J, Cassisi N J. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale.  Head Neck . 2001;  23 363-371
  • 9 Brewis C, Bottrill I D, Wharton S B, Moffat D A. Metastases from glomus jugulare tumors.  J Laryngol Otol . 2000;  114 17-23
  • 10 Schwaber M K, Gussack G S, Kirkpatrick W. The role of radiation therapy in the management of catecholamine-secreting glomus tumors.  Otolaryngol Head Neck Surg . 1988;  98 150-154
  • 11 Duke W W, Boshell B R, Soteres P, Carr J H. A norepinephrine-secreting glomus jugulare tumor presenting as a pheochromocytoma.  Ann Intern Med . 1964;  60 1040-1047
  • 12 Spector G J, Compagno J, Perez C A, Maisel R H, Ogura J H. Glomus jugulare tumors: effects of radiotherapy.  Cancer . 1975;  35 1316-1321
  • 13 Reuland P, Overkamp D, Aicher K P, Bien S, Muller-Schauenburg W, Feine U. Catecholamine secreting glomus tumor detected by iodine-123-MIBG scintigraphy.  J Nucl Med . 1996;  37 463-465
  • 14 Matishak M Z, Symon L, Cheeseman A, Pamphlett R. Catecholamine-secreting paragangliomas of the base of the skull.  J Neurosurg . 1987;  66 604-608
  • 15 Tannir N M, Cortas N, Allam C. A functioning catecholamine-secreting vagal body tumor.  Cancer . 1983;  52 932-935
  • 16 Mukherjee J J, Kaltsas G A, Islam N. Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine.  Clin Endocrinol (Oxf) . 2001;  55 47-60
    >